Understanding NT Pro BNP Test For Cardiac Screening In Diabetes Patients with Dr Sandeep Sewlikar - Video

Science has been fighting this menace for long years and with the advent of insulin in 1921, mankind started having an edge towards controlling this menace. The 20th century has seen a different perspective on the management of diabetes mellitus apart from controlling the glycemic level. The thrust of management has shifted towards cardiovascular protection because more deaths are happening from heart attacks or heart failure than because of glycemic complications of diabetes.

In the process, Roche has introduced the NT Pro BNP test, a spot test to rule out heart failure. The medical Dialogues team spoke to Dr. Sandeep Sewlikar, who is the head of medical and scientific affairs for India and neighboring countries, at Roche diagnostics, India,

With over 15 years of experience in the medical affairs and clinical research field, Dr. Sandeep Sewlikar oversees the centralized, point of care, molecular and tissue diagnositcs from a medical and scientific standpoint at Roche diagnostics, India. A graduate from the Govt Medical College, Miraj, Maharashtra, dr Sandeep also holds a PhD from the indian institute of technology, Mumbai.

Disclaimer: This post has been published under MD Brand Connect Initiative and is sponsored by Roche diagnostics.